Stacy Stein, MD, and co-investigators, research omalizumab to treat oxaliplatin hypersensitivity reactions for patients with gastrointestinal cancers.
Kirsten Dooley, BS, APRN
Advertisement
Articles by Kirsten Dooley, BS, APRN
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Potential Rusfertide Approval May Offer More Control of Polycythemia Vera
2
FDA Approves Nivolumab/AVD in Untreated Hodgkin Lymphoma
3
FDA Grants Fast Track Designation to FG001 for High-Grade Glioma Surgery
4
Liquid Biopsies, Blood-Based MCED Tests for Detecting CRC in Young Patients
5